NatWest Group’s Charles River Laboratories CRL Stock Holding History

NatWest Group’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-10,085	Closed	-$641K	–	174
2015 Q3	$641K	Buy	+10,085	New	+$724K	0.01%	248
2015 Q2	–	Sell	-10,220	Closed	-$810K	–	390
2015 Q1	$810K	Buy	10,220 +534	+6%	+$39.4K	0.01%	251
2014 Q4	$617K	Buy	+9,686	New	+$607K	0.01%	282
2013 Q4	–	Sell	-7,006	Closed	-$324K	–	775
2013 Q3	$324K	Sell	7,006 -2,647	-27%	-$121K	0.01%	862
2013 Q2	$396K	Buy	+9,653	New	+$414K	0.01%	633

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NatWest Group's CRL Position: Q4 2015 in Review

NatWest Group sold out of Charles River Laboratories (CRL) in Q4 2015, closing a stake of 10,085 shares — an estimated $641K sold.

NatWest Group first reported a position in CRL in Q2 2013 and held it in 5 quarters. The position peaked at $810K in Q1 2015. 268 funds tracked by Wall St. Rank hold CRL as of Q4 2015.

NatWest Group reported no remaining Charles River Laboratories position as of Q4 2015 after selling out during the quarter.
NatWest Group sold 10,085 Charles River Laboratories shares in Q4 2015, an estimated $641K.
NatWest Group first reported a position in Charles River Laboratories in Q2 2013 and held it in 5 quarters.
NatWest Group's Charles River Laboratories position peaked at $810K in Q1 2015.
268 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.